Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -80.81% | -17.46% | 37.33% | 45.04% | 59.68% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 392.67% | -14.66% | -104.68% | -76.96% | -91.31% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -51.81% | -54.84% | -661.85% | -194.36% | 39.02% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -70.19% | -85.13% | 27.35% | 4.68% | -- |
| Total Debt Repaid | 80.32% | 78.16% | -30.82% | -30.82% | -1,675.00% |
| Issuance of Common Stock | 1,313.59% | 964.45% | 630.47% | 62.43% | -83.89% |
| Repurchase of Common Stock | -- | -- | 52.57% | 52.57% | 52.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -2,269.81% | 330.89% | -- |
| Cash from Financing | 27.31% | -16.72% | 341.05% | 53.51% | 423.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -271.80% | -353.38% | -266.50% | -1,845.49% | 105.71% |